Online citations, reference lists, and bibliographies.

Dementia Risk With Antihypertensive Use And Blood Pressure Variability

P. Tully, J. Dartigues, S. Debette, C. Helmer, S. Artéro, C. Tzourio
Published 2016 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Objective: To determine the association between discrete antihypertensive drug classes and incident dementia controlling for blood pressure variability (BPV) in the preceding 4 years. Methods: A total of 6,537 participants (mean age 79 years, 62% women) in a prospective population-based cohort were followed up for incident dementia. A 4-year time lag period was created to classify drug exposure and measure blood pressure. BPV (percent coefficient of variation [CV]) was regressed against 9 antihypertensive drug classes (BPVreg). Cox regression models were employed to determine hazard ratios (HRs) for incident dementia thereafter according to drug class, adjusted for mean blood pressure, covariates, and BPV or BPVreg. Results: Over a median 8.4 years follow-up (interquartile range 6.7–9.0), lower dementia risk was associated with nondihydropyridine calcium channel blocker (HR 0.56; 95% confidence interval [CI] 0.31–1.00, p = 0.05) and loop diuretics (HR 0.45; 95% CI 0.22–0.93, p = 0.03) after adjusting for CV-BPV. Similar findings were obtained in analyses restricted to antihypertensive drug users for nondihydropyridine calcium channel blocker (HR 0.52; 95% CI 0.28–0.95, p = 0.03) and loop diuretics (HR 0.40; 95% CI 0.19–0.83, p = 0.01). All systolic BPV × antihypertensive drug interaction terms were not different from p < 0.05. Conclusions: Nondihydropyridine calcium channel blocker and loop diuretics were associated with a reduced dementia risk independent of CV-BPV in the preceding 4 years. Systolic BPV was not the primary mechanism through which antihypertensive drug classes lower dementia risk.
This paper references
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.
Kdoqi Disclaimer (2002)
Blood Pressure Lowering Medication, Visit-to-Visit Blood Pressure Variability, and Cognitive Function in Old Age.
Liselotte W Wijsman (2016)
Angiotensin Converting Enzyme Inhibitors and the Reduced Risk of Alzheimer’s Disease in the Absence of Apolipoprotein E4 Allele
W. Qiu (2013)
Calcium channel blockers and risk of AD: the Baltimore Longitudinal Study of Aging
S. Yaşar (2005)
Depression history, depressive symptoms, and incident dementia: the 3C Study.
H. Lenoir (2011)
Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension
P. Rothwell (2010)
The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study.
F. Forette (2002)
Prevalence, awareness, treatment, and control of hypertension in the elderly: the Three City study
P. Brindel (2006)
A systematic review of calcium channel blocker use and cognitive decline/dementia in the elderly
R. Peters (2014)
Goodpasture syndrome during the course of a Schönlein-Henoch purpura.
L. Carreras (2002)
Diuretic antihypertensive drugs and incident dementia risk: a systematic review, meta-analysis and meta-regression of prospective studies
P. Tully (2016)
Use of diuretics is associated with reduced risk of Alzheimer's disease: the Cache County Study
Yi-Fang Chuang (2014)
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR)
D. Segal (2010)
Synthesis and pharmacology of pyrid-3-yl sulfonylureas and thioureas as astrocytic Na+ 2Cl- K+ cotransporter inhibitors
B. Masereel (1994)
The CES-D Scale
L. S. Radloff (1977)
Antihypertensive Agents and Risk of Parkinson’s Disease, Essential Tremor and Dementia: A Population-Based Prospective Study (NEDICES)
E. Louis (2009)
Association Between Annual Visit-to-Visit Blood Pressure Variability and Stroke in Postmenopausal Women: Data From the Women's Health Initiative
D. Shimbo (2012)
Blood pressure variability and risk of dementia in an elderly cohort, the Three-City Study
A. Alpérovitch (2014)
Relation between uric acid and Alzheimer's disease in elderly Jordanians.
E. Al-khateeb (2015)
Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. Washington, DC: American Psychiatric Association
Visitto-visit blood pressure variations: new independent determinants for cognitive function in the elderly at high risk of cardiovascular disease
M Nagai (2012)
Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study.
M. Morris (2001)
Diuretic use is associated with better learning and memory in older adults in the Ginkgo Evaluation of Memory study
S. Yasar (2012)
Synthesis and pharmacology of pyrid-3-yl sulfonylureas and thioureas as astrocytic Na1 2C12 K1 cotransporter inhibitors
B Masereel (1994)
Diuretics in the treatment of hypertension. Part 2: loop diuretics and potassium-sparing agents
J. Tamargo (2014)
Antihypertensive drug use, blood pressure variability, and incident stroke risk in older adults: ThreeCity cohort study. Stroke 2016;47:1194–1200
PJ Tully (2016)
World Health Organization. Guidelines for ATC Classification and DDD Assignment. Oslo: Norwegian Institute of Public Health
Measurement-to-Measurement Blood Pressure Variability Is Related to Cognitive Performance: The Maine Syracuse Study
G. Crichton (2014)
Angiotensin receptor blockers and risk of dementia: cohort study in UK Clinical Practice Research Datalink
K L Goh (2015)
No Adjustments Are Needed for Multiple Comparisons
K. Rothman (1990)
Occurrence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use.
Z. Guo (1999)
Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis
N. Li (2010)
Duration of antihypertensive drug use and risk of dementia: A prospective cohort study
J. Blass (2009)
Calcium dyshomeostasis and intracellular signalling in alzheimer's disease
F. Laferla (2002)
Selective Antihypertensive Dihydropyridines Lower Aβ Accumulation by Targeting both the Production and the Clearance of Aβ across the Blood-Brain Barrier
D. Paris (2011)
Antihypertensive drugs decrease risk of Alzheimer disease
S. Yasar (2013)
Antihypertensive Drug Use, Blood Pressure Variability, and Incident Stroke Risk in Older Adults: Three-City Cohort Study
P. Tully (2016)
K/DOQI clinical practice guidelines for chronic kidney disease
A. Levey (2002)
Primary prevention with lipid lowering drugs and long term risk of vascular events in older people: population based cohort study
A. Alpérovitch (2015)
Redefined Blood Pressure Variability Measure and Its Association With Mortality in Elderly Primary Care Patients
S. Gao (2014)
Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function.
M. Froissart (2005)
Visit-to-visit blood pressure variations: new independent determinants for cognitive function in the elderly at high risk of cardiovascular disease
M. Nagai (2012)
Vascular Factors and Risk of Dementia: Design of the Three-City Study and Baseline Characteristics of the Study Population
M. Antoniak (2003)
Degree of blood pressure reduction and recurrent stroke: the PROGRESS trial
H. Arima (2014)
Association of visit-to-visit variability in blood pressure with cognitive function in old age: prospective cohort study
B. Sabayan (2013)
Evidence for a Neuroprotective Effect of Pyrid‐3‐yl‐sulphonylurea in Photochemically Induced Focal Ischaemia in Rats: Magnetic Resonance Imaging Evaluation
C. Baudelet (1999)

This paper is referenced by
From Brain Disease to Brain Health: Primary Prevention of Alzheimer's Disease and Related Disorders in a Health System Using an Electronic Medical Record-Based Approach.
Anne Marie Fosnacht (2017)
Antihypertensive Medication Regimen Intensity and Incident Dementia in an Older Population.
Edwin C. K. Tan (2018)
Blood Pressure in Different Dementia Disorders, Mild Cognitive Impairment, and Subjective Cognitive Decline
Knut Hestad (2020)
Does Treating Vascular Risk Factors Prevent Dementia and Alzheimer's Disease? A Systematic Review and Meta-Analysis.
S. Larsson (2018)
Blood Pressure and Risks of Cognitive Impairment and Dementia
Ya-Nan Ou (2020)
Association between Antihypertensive Drug Use and the Incidence of Cognitive Decline and Dementia: A Meta-Analysis of Prospective Cohort Studies
Guangli Xu (2017)
Effect of Long-Term Vascular Care on Progression of Cerebrovascular Lesions: Magnetic Resonance Imaging Substudy of the PreDIVA Trial (Prevention of Dementia by Intensive Vascular Care)
J. W. van Dalen (2017)
Pay attention to the role of blood pressure variability in the pathogenesis, prevention and treatment of cerebral small vessel disease
Y. Fan (2016)
The association between systolic blood pressure variability with depression, cognitive decline and white matter hyperintensities: the 3C Dijon MRI study.
Phillip J Tully (2018)
Lower dementia risk with different classes of antihypertensive medication in older patients
Tessa van Middelaar (2017)
Visit-to-Visit Blood Pressure Variability and Alzheimer's Disease: Links and Risks.
M. Nagai (2017)
Calcium channel blocker use reduces incident dementia risk in elderly hypertensive patients: A meta-analysis of prospective studies
S. Hussain (2018)
Long-Term Subclinical Hyperglycemia and Hypoglycemia as Independent Risk Factors for Mild Cognitive Impairment in Elderly People.
F. Wang (2017)
Age of onset of hypertension and risk of dementia in the oldest-old: The 90+ Study
M. Corrada (2017)
Role and Relevance of Blood Pressure Variability in Hypertension Related Co-morbidities.
A. Kumar (2017)
Variability in metabolic parameters and risk of dementia: a nationwide population-based study
S. Lee (2018)
Visit‐to‐visit variability in blood pressure and Alzheimer's disease
S. Lattanzi (2018)
Drug interactions with dementia‐related pathophysiological pathways worsen or prevent dementia
Romain Barus (2019)
Semantic Scholar Logo Some data provided by SemanticScholar